3rd Annual Executing Global Clinical Trials
13th September 2012 — 14th September 2012
How to Globalize Your Study for Clinical Success
What are the strategies in which we can be more efficient and develop higher quality data at less cost with our global clinical trials? How do we get access to international resources? How can we trust human subject protection is safe? How can we trust the quality of the data?
In our 3rd year of tracking the progress and advancements to the challenges of executing global clinical trials, we bring fresh perspectives and a new agenda addressing:
- Risk Based Monitoring – What Does it Mean for Your Global Study?
How do We Meet the Challenges of Outsourcing and Globalization?
- Investigator Non-Compliance and Protocol Deviation
Social Media Techniques and Mobile Technologies to Advance Global Patient Engagement
- Special Issues in Conducting Global Trials for Rare Diseases and Targeted Therapies
New perspective with an industry veteran on Ethical Considerations in Global Clinical Trials
- The Future of Drug Development in Asia/Emerging Markets
Global Clinical Supply Chain Risk Management Strategies
New Approaches to Ensuring Data Quality in Global Clinical Trials
- Working Across Cultures
- 3rd Annual Regional Roundtables -
One of the best rated sections of the conference is the regional round tables for one-on-one questions with an expert in the following areas:
China ● EU ● Latin America ● India ● Russia/Ukraine ● Canada
Brazil ● Eastern Europe ● Australia ● Korea
You will have access to a partnering tool for one-on-one meetings as well as several networking breaks, a luncheon and reception.
When we think about global clinical trials, how do we ensure that we take in the whole scope to include regulations, country specific feasibility, infrastructure, training, support, diversity of locations, patients, culture, etc? These are some of the questions we present strategic ideas and solutions to at the 3rd annual event.
“Excellent Hospitality and team work. Congenial and friendly atmosphere with fostered communication between speakers and attendees. Good job!”
Honorio Silva, IAFCR
“Roundtables- Great idea! Good way to share specific experiences.”
Felicia Favorito, Millennium Pharmaceuticals
Sergey Borisov, BBK Worldwide
Linda Strause, Vical Inc.
“Good organization, strong speakers, enough opportunity for Q&A from attendees and networking cocktail hour were excellent. Overall, I thought the conference was very well organized and orchestrated. Kudos!”
Matt Whalen, PhD, IMPACT LLC
“Knowledgeable and interesting, interactive and provocative.”
Brian Schrock, Eli Lilly & Co.
Lisa McKerracher, BioAxone
“The speakers were extremely knowledgeable and I was particularly impressed with the way everyone was so willing to share information.”
Jamila Watkins, MBA, Merck Research Laboratories
“Very useful and practical information, very interactive meeting... New cutting edge info, new approaches- informative... Excellent, relevant, informative.”
Joan T. Butler, The George Washington University
John Hedberg, RPS
“Thank you so much for having me here. I’ve gained a lot of information regarding Global Clinical Trials & will use.”
Aquanette T. Sass, Merck
“Outstanding session with fantastic goals for training and certification.”
MC Sullivan, MD, Caligor Rx
“Very good! Exceeded my expectations.”
Tammy Bishop, Caligor RX
“Excellent Data, fun, interesting.”
Mark Szuch, UCB
“Overall Engaging, excellent... Very balanced, important insights, factual, nice layout.”
Aleksandar Skuban, MD, Merck
This conference is designed for pharmaceutical and biotech executives in senior management or director roles
Expected Number of Attendees
View Conference Website: 3rd Annual Executing Global Clinical Trials
Price of Attendance
10% discount code BPGCT
Fairmont Copley Plaza in Boston
138 St. James Avenue